{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:58:50Z","timestamp":1795021130453,"version":"4.10.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:00:00Z","timestamp":1793750400000},"content-version":"vor","delay-in-days":116,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["Process number 2023\/10706-0"],"award-info":[{"award-number":["Process number 2023\/10706-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Health in PRONON","award":["\"Retratos da Mama\" Processo NUP: 25000.069252\/2015-79"],"award-info":[{"award-number":["\"Retratos da Mama\" Processo NUP: 25000.069252\/2015-79"]}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["Call 16\/2023, Process #444127\/2023-2"],"award-info":[{"award-number":["Call 16\/2023, Process #444127\/2023-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Breast Cancer"],"DOI":"10.1038\/s41523-026-01005-z","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T07:56:54Z","timestamp":1783756614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ensemble machine learning for predicting breast cancer recurrence and mortality using clinical and hemogram data"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5667-0675","authenticated-orcid":false,"given":"Patricia Honorato","family":"Moreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7943-9715","authenticated-orcid":false,"given":"Arthur Shuzo Owtake","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3425-0273","authenticated-orcid":false,"given":"Rafael de","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6096-116X","authenticated-orcid":false,"given":"Joaquim Gasparini dos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5818-922X","authenticated-orcid":false,"given":"Renata Colombo","family":"Bonadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3796-232X","authenticated-orcid":false,"given":"Wesley Antonio Lopes de","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7806-4117","authenticated-orcid":false,"given":"Thomas de Almeida","family":"Reichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9567-1066","authenticated-orcid":false,"given":"Bruna Salani","family":"Mota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4681-3069","authenticated-orcid":false,"given":"Alexandre Ferreira","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3421-1984","authenticated-orcid":false,"given":"Flavia","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0342-8726","authenticated-orcid":false,"given":"Roger","family":"Chammas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8633-716X","authenticated-orcid":false,"given":"Luciana Rodrigues Carvalho","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"1005_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"1005_CR2","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","volume":"24","author":"A Goldhirsch","year":"2013","unstructured":"Goldhirsch, A. et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International expert consensus on the primary therapy of early breast cancer 2013. Ann. Oncol. 24, 2206\u20132223 (2013).","journal-title":"Ann. Oncol."},{"key":"1005_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJMoa2202809","volume":"387","author":"J Cortes","year":"2022","unstructured":"Cortes, J. et al. Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer. N. Engl. J. Med. 387, 217\u2013226 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1005_CR4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa1910549","volume":"382","author":"P Schmid","year":"2020","unstructured":"Schmid, P. et al. Pembrolizumab for early triple-negative breast cancer. N. Engl. J. Med. 382, 810\u2013821 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1005_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02176-8","volume":"23","author":"M Jin","year":"2024","unstructured":"Jin, M. et al. PD-1\/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies. Mol. Cancer 23, 266 (2024).","journal-title":"Mol. Cancer"},{"key":"1005_CR6","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.3389\/fimmu.2020.01779","volume":"11","author":"W Zhang","year":"2020","unstructured":"Zhang, W. et al. A Rosetta stone for breast cancer: prognostic value and dynamic regulation of neutrophil in tumor microenvironment. Front. Immunol. 11, 1779 (2020).","journal-title":"Front. Immunol."},{"key":"1005_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-016-0794-1","volume":"19","author":"J-L Ethier","year":"2017","unstructured":"Ethier, J.-L., Desautels, D., Templeton, A., Shah, P. S. & Amir, E. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. Breast Cancer Res. 19, 2 (2017).","journal-title":"Breast Cancer Res."},{"key":"1005_CR8","doi-asserted-by":"publisher","first-page":"e447","DOI":"10.1093\/oncolo\/oyad303","volume":"29","author":"SS Faria","year":"2024","unstructured":"Faria, S. S. et al. Development of a prognostic model for early breast cancer integrating neutrophil to lymphocyte ratio and clinical-pathological characteristics. Oncologist 29, e447\u2013e454 (2024).","journal-title":"Oncologist"},{"key":"1005_CR9","doi-asserted-by":"publisher","first-page":"104553","DOI":"10.1016\/j.breast.2025.104553","volume":"83","author":"GB Polho","year":"2025","unstructured":"Polho, G. B. et al. Central nervous system relapse in triple-negative breast cancer patients achieving pathological complete response after neoadjuvant chemotherapy: a retrospective cohort analysis. Breast 83, 104553 (2025).","journal-title":"Breast"},{"key":"1005_CR10","first-page":"2034","volume":"19","author":"GB Polho","year":"2025","unstructured":"Polho, G. B. et al. Neutrophil-to-lymphocyte ratio predicts long-term survival in early triple negative breast cancer treated with neoadjuvant chemotherapy. eCancer Med. Sci. 19, 2034 (2025).","journal-title":"eCancer Med. Sci."},{"key":"1005_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-025-02129-z","volume":"27","author":"R Zhang","year":"2025","unstructured":"Zhang, R. et al. Multimodal deep learning model for prediction of breast cancer recurrence risk and correlation with oncotype DX. Breast Cancer Res. 27, 178 (2025).","journal-title":"Breast Cancer Res."},{"key":"1005_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-023-02377-z","volume":"23","author":"D Zuo","year":"2023","unstructured":"Zuo, D. et al. Machine learning-based models for the prediction of breast cancer recurrence risk. BMC Med. Inform. Decis. Mak. 23, 276 (2023).","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"1005_CR13","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.3390\/cancers16223799","volume":"16","author":"SW Park","year":"2024","unstructured":"Park, S. W. et al. Mortality prediction modeling for patients with breast cancer based on explainable machine learning. Cancers (Basel) 16, 3799 (2024).","journal-title":"Cancers (Basel)"},{"key":"1005_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08240-2","volume":"7","author":"Z Zhu","year":"2017","unstructured":"Zhu, Z. et al. Prognostic value of routine laboratory variables in prediction of breast cancer recurrence. Sci. Rep. 7, 8135 (2017).","journal-title":"Sci. Rep."},{"key":"1005_CR15","doi-asserted-by":"publisher","first-page":"1000522","DOI":"10.3389\/fsurg.2023.1000522","volume":"10","author":"J-M Yin","year":"2023","unstructured":"Yin, J.-M. et al. Is red cell distribution width a prognostic factor in patients with breast cancer? A meta-analysis. Front. Surg. 10, 1000522 (2023).","journal-title":"Front. Surg."},{"key":"1005_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-23593-9","volume":"15","author":"P Karthikeyan","year":"2025","unstructured":"Karthikeyan, P., Malaserene, I. & Deepakraj, E. Explainable AI based cervical cancer prediction using FSAE feature engineering and H2O AutoML. Sci. Rep. 15, 40439 (2025).","journal-title":"Sci. Rep."},{"key":"1005_CR17","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.21037\/tcr-22-1626","volume":"11","author":"C Ladbury","year":"2022","unstructured":"Ladbury, C. et al. Utilization of model-agnostic explainable artificial intelligence frameworks in oncology: a narrative review. Transl. Cancer Res. 11, 3853\u20133868 (2022).","journal-title":"Transl. Cancer Res."},{"key":"1005_CR18","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.3390\/healthcare13172154","volume":"13","author":"Q Abbas","year":"2025","unstructured":"Abbas, Q., Jeong, W. & Lee, S. W. Explainable AI in clinical decision support systems: a meta-analysis of methods, applications, and usability challenges. Healthcare (Basel) 13, 2154 (2025).","journal-title":"Healthcare (Basel)"},{"key":"1005_CR19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1186\/s12905-025-04120-4","volume":"25","author":"L Zhu","year":"2025","unstructured":"Zhu, L., Qiao, J., Yang, C., Ruan, X. & Wu, S. Prognostic value of lymphocyte-to-monocyte ratio for breast cancer: a systematic review and meta-analysis. BMC Women\u2019s Health 25, 569 (2025).","journal-title":"BMC Women\u2019s Health"},{"key":"1005_CR20","doi-asserted-by":"publisher","first-page":"e074874","DOI":"10.1136\/bmjopen-2023-074874","volume":"13","author":"X Qi","year":"2023","unstructured":"Qi, X. et al. Prognostic significance of platelet-to-lymphocyte ratio (PLR) in patients with breast cancer treated with neoadjuvant chemotherapy: a meta-analysis. BMJ Open 13, e074874 (2023).","journal-title":"BMJ Open"},{"key":"1005_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-47874-3","volume":"13","author":"SI Moukas","year":"2023","unstructured":"Moukas, S. I. et al. Ratios of monocytes and neutrophils to lymphocytes in the blood predict benefit of CDK4\/6 inhibitor treatment in metastatic breast cancer. Sci. Rep. 13, 21262 (2023).","journal-title":"Sci. Rep."},{"key":"1005_CR22","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.21037\/gs-24-106","volume":"13","author":"X Song","year":"2024","unstructured":"Song, X. et al. Prognostic prediction of breast cancer patients using machine learning models: a retrospective analysis. Gland Surg. 13, 1575\u20131587 (2024).","journal-title":"Gland Surg."},{"key":"1005_CR23","doi-asserted-by":"crossref","unstructured":"Silveira, J. A., da Silva A. R. & de Lima M. Z. T. Harnessing artificial intelligence for predicting breast cancer recurrence: a systematic review of clinical and imaging data. Discov Oncol. 16, 135 (2025).","DOI":"10.1007\/s12672-025-01908-6"},{"key":"1005_CR24","doi-asserted-by":"publisher","first-page":"10659","DOI":"10.1007\/s00432-023-04967-w","volume":"149","author":"D Lu","year":"2023","unstructured":"Lu, D. et al. Predictive value of machine learning for breast cancer recurrence: a systematic review and meta-analysis. J. Cancer Res. Clin. Oncol. 149, 10659\u201310674 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"1005_CR25","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.3390\/cancers12123817","volume":"12","author":"S-J Lou","year":"2020","unstructured":"Lou, S.-J. et al. Machine learning algorithms to predict recurrence within 10 years after breast cancer surgery: a prospective cohort study. Cancers (Basel) 12, 3817 (2020).","journal-title":"Cancers (Basel)"},{"key":"1005_CR26","doi-asserted-by":"publisher","first-page":"596364","DOI":"10.3389\/fonc.2021.596364","volume":"11","author":"J-Y Kim","year":"2021","unstructured":"Kim, J.-Y. et al. Deep learning-based prediction model for breast cancer recurrence using adjuvant breast cancer cohort in tertiary cancer center registry. Front. Oncol. 11, 596364 (2021).","journal-title":"Front. Oncol."},{"key":"1005_CR27","doi-asserted-by":"publisher","first-page":"e80240","DOI":"10.1371\/journal.pone.0080240","volume":"8","author":"Y Koma","year":"2013","unstructured":"Koma, Y. et al. Increased red blood cell distribution width associates with cancer stage and prognosis in patients with lung cancer. PLoS ONE 8, e80240 (2013).","journal-title":"PLoS ONE"},{"key":"1005_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72585-4","volume":"10","author":"B Song","year":"2020","unstructured":"Song, B. et al. Utility of red cell distribution width as a diagnostic and prognostic marker in non-small cell lung cancer. Sci. Rep. 10, 15717 (2020).","journal-title":"Sci. Rep."},{"key":"1005_CR29","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.18632\/oncotarget.13679","volume":"8","author":"C-L Lee","year":"2017","unstructured":"Lee, C.-L. et al. Hemoglobin level trajectories in the early treatment period are related with survival outcomes in patients with breast cancer. Oncotarget 8, 1569\u20131579 (2017).","journal-title":"Oncotarget"},{"key":"1005_CR30","doi-asserted-by":"publisher","first-page":"bbae699","DOI":"10.1093\/bib\/bbae699","volume":"26","author":"H Yang","year":"2024","unstructured":"Yang, H. et al. Multimodal deep learning approaches for precision oncology: a comprehensive review. Brief. Bioinform. 26, bbae699 (2024).","journal-title":"Brief. Bioinform."},{"key":"1005_CR31","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.222733","volume":"307","author":"VA Arasu","year":"2023","unstructured":"Arasu, V. A. et al. Comparison of mammography AI algorithms with a clinical risk model for 5-year breast cancer risk prediction: an observational study. Radiology 307, e222733 (2023).","journal-title":"Radiology"},{"key":"1005_CR32","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2147\/CMAR.S514693","volume":"17","author":"T-F Lee","year":"2025","unstructured":"Lee, T.-F. et al. A machine learning model for predicting breast cancer recurrence and supporting personalized treatment decisions through comprehensive feature selection and explainable ensemble learning. Cancer Manag. Res. 17, 917\u2013932 (2025).","journal-title":"Cancer Manag. Res."},{"key":"1005_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.breast.2020.10.001","volume":"54","author":"M Caleffi","year":"2020","unstructured":"Caleffi, M. et al. Breast cancer survival in Brazil: how much health care access impact on cancer outcomes? Breast 54, 155\u2013159 (2020).","journal-title":"Breast"},{"key":"1005_CR34","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","volume":"385","author":"GS Collins","year":"2024","unstructured":"Collins, G. S. et al. TRIPOD\u2009+\u2009AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ 385, e078378 (2024).","journal-title":"BMJ"},{"key":"1005_CR35","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1177\/09622802251338983","volume":"34","author":"O Kalayc\u0131o\u011flu","year":"2025","unstructured":"Kalayc\u0131o\u011flu, O. et al. Evaluating the sample size requirements of tree-based ensemble machine learning techniques for clinical risk prediction. Stat. Methods Med. Res. 34, 1356\u20131372 (2025).","journal-title":"Stat. Methods Med. Res."},{"key":"1005_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-024-02173-x","volume":"24","author":"J Li","year":"2024","unstructured":"Li, J. et al. Comparison of the effects of imputation methods for missing data in predictive modelling of cohort study datasets. BMC Med. Res. Methodol. 24, 41 (2024).","journal-title":"BMC Med. Res. Methodol."},{"key":"1005_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-023-02060-x","volume":"23","author":"C Feng","year":"2023","unstructured":"Feng, C., Li, L. & Xu, C. Advancements in predicting and modeling rare event outcomes for enhanced decision-making. BMC Med. Res. Methodol. 23, 243 (2023).","journal-title":"BMC Med. Res. Methodol."},{"key":"1005_CR38","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0893-6080(05)80023-1","volume":"5","author":"DH Wolpert","year":"1992","unstructured":"Wolpert, D. H. Stacked generalization. Neural Netw. 5, 241\u2013259 (1992).","journal-title":"Neural Netw."},{"key":"1005_CR39","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10654-018-0390-z","volume":"33","author":"AI Naimi","year":"2018","unstructured":"Naimi, A. I. & Balzer, L. B. Stacked generalization: an introduction to super learning. Eur. J. Epidemiol. 33, 459\u2013464 (2018).","journal-title":"Eur. J. Epidemiol."},{"key":"1005_CR40","doi-asserted-by":"crossref","unstructured":"He, H., Bai, Y., Garcia, E. A. & Li, S. ADASYN: adaptive synthetic sampling approach for imbalanced learning. in 2008 IEEE International Joint Conference on Neural Networks (IJCNN) 1322\u20131328 (IEEE, 2008).","DOI":"10.1109\/IJCNN.2008.4633969"},{"key":"1005_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1175\/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2","volume":"78","author":"GW Brier","year":"1950","unstructured":"Brier, G. W. Verification of forecasts expressed in terms of probability. Mon. Weather Rev. 78, 1\u20133 (1950).","journal-title":"Mon. Weather Rev."},{"key":"1005_CR42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden, W. J. Index for rating diagnostic tests. Cancer 3, 32\u201335 (1950).","journal-title":"Cancer"},{"key":"1005_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-023-00530-5","volume":"9","author":"FM Howard","year":"2023","unstructured":"Howard, F. M. et al. Integration of clinical features and deep learning on pathology for the prediction of breast cancer recurrence assays and risk of recurrence. npj Breast Cancer 9, 25 (2023).","journal-title":"npj Breast Cancer"},{"key":"1005_CR44","doi-asserted-by":"crossref","unstructured":"Efron, B. & Tibshirani, R. J. An Introduction to the Bootstrap (Chapman & Hall\/CRC, 1994).","DOI":"10.1201\/9780429246593"},{"key":"1005_CR45","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong, E. R., DeLong, D. M. & Clarke-Pearson, D. L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44, 837\u2013845 (1988).","journal-title":"Biometrics"}],"container-title":["npj Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-01005-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-01005-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-01005-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:05:55Z","timestamp":1793833555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-01005-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1005"],"URL":"https:\/\/doi.org\/10.1038\/s41523-026-01005-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8374118\/v1","asserted-by":"object"}]},"ISSN":["2374-4677"],"issn-type":[{"value":"2374-4677","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.C.B. declares speaker fees and\/or honoraria for consulting or advisory functions: Daiichi-Sankyo, Nestle Health Science, Addium, Gilead, MSD, BMS, AstraZeneca, Ache, Pfizer, Roche, Novartis, Libbs, Lilly, GSK; financial support for educational programs and symposia: AstraZeneca, Daiichi-Sankyo, MSD, Lilly, Roche, Novartis; institutional Research grant: Novartis, AstraZeneca, Gilead. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"142"}}